查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1629232

碘帕醇注射市場，按類型、應用、國家和地區 - 2025-2032 年全球行業分析、市場規模、市場佔有率和預測

Iopamidol Injection Market, By Type, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 316 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2024年碘帕醇注射劑市場規模為15.916億美元，2025年至2032年複合年成長率為4.50%。

碘帕醇注射市場-市場動態

慢性病盛行率上升

癌症、神經系統疾病和心血管疾病等慢性疾病病例的不斷增加是推動碘帕醇注射市場的主要原因之一。為了準確診斷和製定治療計劃，許多疾病經常需要複雜的影像技術。由於碘帕醇（一種非離子型水溶性造影劑）在各種影像方式（包括 CT 掃描、血管攝影和脊髓造影）的廣泛使用，其需求大大增加。推動市場的其他因素包括成像技術的不斷發展，提高診斷過程的精確度和有效性。此外，隨著年齡的成長，診斷影像治療的必要性也隨之增加，因為慢性病在老年人中更為常見。由於老年人更容易罹患癌症、神經系統問題和心血管疾病等疾病，因此對碘帕醇等造影劑的需求增加。此外，隨著早期疾病診斷知識的增加，預防性醫療保健實踐的興起是推動市場擴張的主要因素。

碘帕醇注射市場-關鍵洞察

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2025-2032 年）每年將以 4.50% 左右的複合年成長率成長

根據類型細分，預計 9 g I/30 mL 將在 2024 年顯示最大的市場佔有率

根據應用細分，2024年醫院是領先的應用

按地區分類，北美是 2024 年的主要收入來源

碘帕醇注射市場-細分分析：

全球碘帕醇注射市場根據類型、應用和地區進行細分。

依類型，市場分為兩類：9 g I/30 mL 和 11.1 g I/30 mL。由於其廣泛應用於診斷影像程序，包括電腦斷層掃描 (CT) 掃描和血管造影，9 g I/30 mL 碘帕醇注射市場正在顯著擴大。由於其理想的碘含量，可以最大限度地提高成像對比度，同時降低患者風險，因此該濃度是特別優選的。由於心血管和神經系統疾病等慢性病盛行率不斷上升，對精確和非侵入性診斷解決方案的需求不斷成長，進一步推動了這一類別的採用。

根據應用，市場分為醫院、診所和其他。由於提供廣泛的診斷和治療服務，醫院是最大的類別。由於醫院患者量大且影像設備先進，碘帕醇注射經常在醫院使用。該細分市場對碘帕醇的需求是由醫院進行的影像檢查數量不斷增加以及慢性疾病的發病率所推動的。醫院強調提供精確有效的診斷服務，進一步促進了市場擴張。

碘帕醇注射市場-地理洞察

由於癌症和心血管疾病等需要診斷影像的慢性疾病發生率不斷上升，預計北美地區碘帕醇注射市場將顯著擴大。由於北美地區完善的醫療基礎設施和現代成像技術的高採用率，該市場正在擴大。此外，診斷影像研究的融資、政府的支持性舉措以及主要市場競爭對手的存在也有助於該地區的擴張。

由於人口老化和診斷影像技術的進步，歐洲碘帕醇注射市場預計將穩定成長。該市場由德國、英國和法國等國家主導，因為它們擁有先進的醫療保健系統和高昂的醫療支出。進一步推動市場擴張的是最先進的影像技術的結合以及對非侵入性診斷技術的日益重視。確保碘帕醇等造影劑安全性和有效性的嚴格監管框架也使該地區受益，從而增加了這些藥物在整個歐洲診斷成像應用中的使用。

碘帕醇注射市場-競爭格局：

GE Healthcare、Bayer AG、Aviceena Pharmaceutical LLC、Sun Pharmaceutical Industries Ltd.、Bracco Diagnostics Inc.、Sanochemia Pharmazeutika GmbH 等幾家主要競爭對手都在積極從事研發、產品創新和戰略合作夥伴關係，從而定義了該公司的競爭格局。企業正集中精力發展產品線，使產品更安全、更有效，並透過併購提高市場佔有率。競爭格局由多種因素驅動，包括技術進步、監管許可以及適應患者和醫療保健提供者不斷變化的需求的能力。為了增加客戶群並獲得競爭優勢，主要行業參與者也在行銷和分銷策略上進行投資。

目錄

第1章：碘帕醇注射劑市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 碘帕醇注射液市場片段（按類型）
    • 碘帕醇注射液市場片段（依應用）
    • 碘帕醇注射市場片段（依國家）
    • 碘帕醇注射液市場區域分析
  • 競爭洞察

第 3 章：碘帕醇注射主要市場趨勢

  • 碘帕醇注射劑市場促進因素
    • 市場促進因素的影響分析
  • 碘帕醇注射劑市場限制
    • 市場限制影響分析
  • 碘帕醇注射液市場機會
  • 碘帕醇注射劑市場未來趨勢

第 4 章：碘帕醇注射劑產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：碘帕醇注射市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：碘帕醇注射市場格局

  • 2024年碘帕醇注射液市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：碘帕醇注射市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 9克/30毫升
    • 11.1 克 I/30 毫升

第 8 章：碘帕醇注射市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 醫院
    • 診所
    • 其他

第 9 章：碘帕醇注射市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 碘帕醇注射液北美主要生產商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 碘帕醇注射液歐洲主要生產商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測（按應用）
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 碘帕醇注射液亞太地區主要生產商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（按應用）
    • 印度
    • 中國
    • 韓國
    • 日本
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 碘帕醇注射劑拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 碘帕醇注射液中東和非洲主要生產商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 10 章：主要供應商分析-碘帕醇注射劑產業

  • 競爭儀表板
  • 公司簡介
    • GE Healthcare
    • Bayer AG
    • Aviceena Pharmaceutical LLC
    • Sun Pharmaceutical Industries Ltd.
    • Bracco Diagnostics Inc.
    • Sanochemia Pharmazeutika GmbH
    • Guerbet Group
    • Jiangsu Hengrui Medicine Co., Ltd.
    • Mahe Medical USA, LLC
    • Hunan Hansen Pharmaceutical Co., Ltd.
    • Taejoon Pharm Co., Ltd.
    • Tianjin Pharmaceutical Holdings Co., Ltd.
    • Others

第 11 章：360 度分析師視角

第 12 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4484

REPORT HIGHLIGHT

Iopamidol Injection Market size was valued at US$ 1,591.6 Million in 2024, expanding at a CAGR of 4.50% from 2025 to 2032.

The non-ionic, water-soluble contrast agent iopamidol injection is mostly used in diagnostic imaging tests such as computed tomography (CT) scans. It is required in order to improve the visibility of internal organs and structures, which facilitates precise diagnosis and treatment planning. This diagnostic breakthrough is especially important for musculoskeletal, neurological, and cardiovascular exams. The market is driven by a number of factors, such as the growing incidence of chronic illnesses like neurological and cardiovascular conditions, the growing need for less invasive diagnostic techniques, and developments in imaging technology. The world's population is getting older, which increases demand as age-related illnesses become more common. The creation of low-dose imaging systems and higher requirements for image quality are two examples of recent technological developments that offer substantial prospects for market growth. Despite these advantages, the market is confronted with obstacles that could hinder its expansion, such as strict regulatory requirements and possible adverse effects linked to iodine-based contrast agents. High prices and restricted supply in developing areas also pose limitations. One promising area of research and development is the creation of safer, more affordable agents with fewer side effects and improved efficacy.

Iopamidol Injection Market- Market Dynamics

Rising Prevalence of Chronic Illness

The growing cases of chronic illnesses like cancer, neurological disorders, and cardiovascular disorders is one of the main reasons driving the market for iopamidol injections. In order to accurately diagnose and plan for therapy, many disorders frequently require sophisticated imaging techniques. Its demand is greatly increased by the widespread use of iopamidol, a non-ionic, water-soluble contrast agent, in various imaging modalities, including CT scans, angiography, and myelography. Additional factors driving the market include ongoing developments in imaging technology that improve the precision and effectiveness of diagnostic processes. Moreover, the necessity for diagnostic imaging treatments increases as people age because chronic diseases are more common in older adults. Because they are more vulnerable to diseases like cancer, neurological problems, and cardiovascular ailments, the aged population increases the need for contrast agents like iopamidol. Furthermore, the rise in preventive healthcare practices that follow the increased knowledge of early disease diagnosis is a major factor driving market expansion.

Iopamidol Injection Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.50% over the forecast period (2025-2032)

Based on type segmentation, the 9 g I/30 mL was predicted to show maximum market share in the year 2024

Based on application segmentation, hospitals were the leading application in 2024

On the basis of region, North America was the leading revenue generator in 2024

Iopamidol Injection Market- Segmentation Analysis:

The Global Iopamidol Injection Market is segmented on the basis of Type, application, and Region.

On the basis of type, the market is segregated into two categories: 9 g I/ 30 mL and 11.1 g I/ 30 mL. Due to its extensive use in diagnostic imaging procedures, including computed tomography (CT) scans and angiography, the 9 g I/30 mL category of the iopamidol injection market is expanding significantly. Because of its ideal iodine content, which maximizes imaging contrast while lowering patient risk, this concentration is especially preferred. The adoption of this category has been further fueled by the growing demand for precise and non-invasive diagnostic solutions due to the rising prevalence of chronic diseases, such as cardiovascular and neurological ailments.

Based on application, the market is divided into Hospitals, Clinics, and Others. Due to their extensive array of diagnostic and therapeutic services, hospitals make up the largest category. Iopamidol injections are often used in hospitals because of their high patient volume and sophisticated imaging equipment. This segment's demand for Iopamidol is driven by the growing number of imaging procedures conducted in hospitals and the incidence of chronic disorders. Market expansion is further aided by hospitals' emphasis on offering precise and effective diagnostic services.

Iopamidol Injection Market- Geographical Insights

The market for iopamidol injection is anticipated to expand significantly in the North American area as a result of the rising incidence of chronic illnesses like cancer and cardiovascular diseases that call for diagnostic imaging. The market is expanding in North American region due to the well-established healthcare infrastructure and the high rate of adoption of modern imaging technologies. Additionally, the region's expansion is aided by financing for diagnostic imaging research, supportive government initiatives, and the presence of major market competitors.

The iopamidol injection market in Europe is expected to grow steadily due to an older population and a rise in diagnostic imaging techniques. The market is led by nations like Germany, the United Kingdom, and France because of their sophisticated healthcare systems and high healthcare spending. Further driving market expansion are the incorporation of state-of-the-art imaging technology and the increasing emphasis on non-invasive diagnostic techniques. Strict regulatory frameworks that guarantee the safety and effectiveness of contrast agents like iopamidol also benefit the region, increasing the use of these drugs in diagnostic imaging applications throughout Europe.

Iopamidol Injection Market- Competitive Landscape:

Several major competitors such as GE Healthcare, Bayer AG, Aviceena Pharmaceutical LLC, Sun Pharmaceutical Industries Ltd., Bracco Diagnostics Inc., Sanochemia Pharmazeutika GmbH, and others are actively engaged in R&D, product innovation, and strategic partnerships define the competitive landscape of the Iopamidol Injection market. Businesses are concentrating on growing their product lines, making their products safer and more effective, and boosting their market share through mergers and acquisitions. The competitive landscape is driven by a number of factors, including technological advancements, regulatory clearances, and the ability to adjust to the evolving needs of patients and healthcare providers. To increase their clientele and gain a competitive edge, major industry players are also investing in marketing and distribution strategies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IOPAMIDOL INJECTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • GE Healthcare
  • Bayer AG
  • Aviceena Pharmaceutical LLC
  • Sun Pharmaceutical Industries Ltd.
  • Bracco Diagnostics Inc.
  • Sanochemia Pharmazeutika GmbH
  • Guerbet Group
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Mahe Medical USA, LLC
  • Hunan Hansen Pharmaceutical Co., Ltd.
  • Taejoon Pharm Co., Ltd.
  • Tianjin Pharmaceutical Holdings Co., Ltd.
  • Others

GLOBAL IOPAMIDOL INJECTION MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • 9 g I/ 30 mL
  • 11.1 g I/ 30 mL

GLOBAL IOPAMIDOL INJECTION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Others

GLOBAL IOPAMIDOL INJECTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Iopamidol Injection Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Iopamidol Injection Market Snippet by Type
    • 2.1.2. Iopamidol Injection Market Snippet by Application
    • 2.1.3. Iopamidol Injection Market Snippet by Country
    • 2.1.4. Iopamidol Injection Market Snippet by Region
  • 2.2. Competitive Insights

3. Iopamidol Injection Key Market Trends

  • 3.1. Iopamidol Injection Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Iopamidol Injection Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Iopamidol Injection Market Opportunities
  • 3.4. Iopamidol Injection Market Future Trends

4. Iopamidol Injection Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Iopamidol Injection Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Iopamidol Injection Market Landscape

  • 6.1. Iopamidol Injection Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Iopamidol Injection Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. 9 g I/ 30 mL
    • 7.1.3. 11.1 g I/ 30 mL

8. Iopamidol Injection Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Hospitals
    • 8.1.3. Clinics
    • 8.1.4. Others

9. Iopamidol Injection Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Iopamidol Injection Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Iopamidol Injection Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7. France
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9. Spain
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10. United Kingdom
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11. Russia
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12. Netherlands
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13. Sweden
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Iopamidol Injection Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8. South Korea
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Iopamidol Injection Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Iopamidol Injection Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Iopamidol Injection Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. GE Healthcare
    • 10.2.2. Bayer AG
    • 10.2.3. Aviceena Pharmaceutical LLC
    • 10.2.4. Sun Pharmaceutical Industries Ltd.
    • 10.2.5. Bracco Diagnostics Inc.
    • 10.2.6. Sanochemia Pharmazeutika GmbH
    • 10.2.7. Guerbet Group
    • 10.2.8. Jiangsu Hengrui Medicine Co., Ltd.
    • 10.2.9. Mahe Medical USA, LLC
    • 10.2.10. Hunan Hansen Pharmaceutical Co., Ltd.
    • 10.2.11. Taejoon Pharm Co., Ltd.
    • 10.2.12. Tianjin Pharmaceutical Holdings Co., Ltd.
    • 10.2.13. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us